CLINICAL ROLE -
Employers and PBMs: Where do They Stand on Prescription Drug Issues?
Employers provide coverage for 56% of the insured population, which carries significant weight with pharmacy benefit managers.
Read More
ACA Silver Plan Premiums Projected to Increase 34% in 2018
Market instability contributes to increasing premiums for 2018 Affordable Care Act health plans.
DIR Fees White Paper Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
Gene Therapy-Immunotherapy Combination Could Reverse Multiple Sclerosis
Combination therapy found to reverse multiple sclerosis in mice models.
Protein Deletion May Eliminate Diabetes Risk
Deleting fatty acid-binding proteins may lead to lifelong metabolic health.
Week in Review: October 27, 2017
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Trending News Today: Trump Declares Opioid Epidemic a Public Health Emergency
Top news of the day from across the healthcare landscape.
Trending News Today: Amazon Receives Pharmacy License in 12 States
Plaque Psoriasis Drug Shows Strong Efficacy Versus Competitors
Risankizumab treats moderate to severe chronic plaque psoriasis.
Single Tablet HIV Regimen Shows Promise
Once-daily HIV treatment found to be highly effective and well-tolerated in treating antiretroviral-naïve HIV-1 patients.
ACIP Makes Recommendations for Changes to 2018 Immunization Schedules
One update reflects the committee’s recommendation of a third dose of mumps-containing vaccine in mumps outbreak settings, as determined by public health authorities.
Pharmacy Times Editor Shares Personal Story, Thanks Her Pharmacist for Helping
As part of American Pharmacists Month, an editor shares her story of how a pharmacist helped her through a scary drug reaction.
Watch
Biosimilars Could Save $54 Billion Over the Next Decade
The emergence of biosimilars will reduce spending on biologics by 3% through 2027.
FDA Approves Treatment for Chemotherapy-Induced Nausea and Vomiting
Varubi indicated for use in combination with other antiemetic agents to treat delayed chemotherapy-induced nausea and vomiting in adults.
Study: Hospitals Mark-Up Drugs Significantly
Drugs administered in an outpatient setting may be marked-up more than 500%.
PI3K Inhibitors Promising for Rare Bone Cancer Therapy
Genome analysis points to potential new treatments for patients with chordoma.
Men Develop Atrial Fibrillation Earlier Than Women
Atrial fibrillation risk increases in men a decade before women.
Investigational Therapy Induces Cancer Cell Death
Novel drug causes apoptosis in leukemia cells, while leaving healthy blood cells unscathed.
Trending News Today: Request to Reinstate Subsidies Blocked by Federal Court
Trending News Today: Gilead HCV Drug Patents Challenged
Influenza Vaccine Coverage Remains Below Healthy People 2020 Targets
The current influenza season is getting off to a typically slow start.
Bipolar Drug Begins Phase 3 Clinical Trials
Trials will evaluate the efficacy of brexpiprazole in patients with bipolar I disorder who experience an acute manic episode, with or without mixed features, requiring hospitalization.
Generic Drug Approvals Continue to Surge
The FDA approved 763 generic drugs in the 2017 fiscal year, which is the highest annual rate since the administration began recording the data.
FDA Grants Dyskinesia Treatment Orphan Drug Designation
Gocovri is the only FDA-approved therapy for dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy.
Monitoring Drug Interactions in Aging Patients With HIV
How pharmacists can reduce polypharmacy and potentially inappropriate prescribing among the aging HIV population.
National Prescription Drug Take Back Day Right Around the Corner
This event will give the public an opportunity to dispose of any unused and unwanted prescription drugs.
10 Natural Remedies to Consider for Treating Anxiety
Here is how to go beyond conventional medicine to help those who suffer from the leading mental health disorder in the United States.
From John Grisham to AJPE: Must-Reads for Pharmacists on Student Loan Debt
Check out the author's new fiction work and the American Journal of Pharmaceutical Education's non-fiction take on this crushing burden.
ACIP Recommends Herpes Zoster Subunit Vaccine
The panel agreed that Shingrix has some superior outcome data; however, some members said it was too early to make the preferential recommendation.
White Paper: DIR Fees Simply Explained
This paper examines the use and implications of direct and indirect remuneration (DIR) fees and potential strategies to overcome the challenges that accompany DIR fees.
